Trek Health's OpenPayer Surpasses 25,000 Monthly Users in Less Than 4 Months
OpenPayer simplifies the time-consuming process of finding payer policies and tracking policy updates. The platform consolidates content from more than 150,000 commercial health plan policies into a single searchable resource, enabling users to quickly locate relevant policies and stay informed about changes that affect reimbursement and operations.
"As payer policies continue to evolve, finding and tracking the right information has become an increasingly time-consuming challenge for provider organizations," said
Trek Health plans to expand the platform with broader payer coverage, enhanced monitoring capabilities and new AI-powered features as OpenPayer continues to grow. The platform's personalized Policy Watchlists already help users automatically track payer policy changes, with additional capabilities planned to further simplify payer policy management.
"The response to OpenPayer has reinforced how much demand exists for a better way to keep up with ever-changing payer policies," Sahota added. "We'll continue to expand the solution and increase the value it delivers to hospitals, health systems, and medical groups across the country."
About Trek Health
Trek Health helps provider organizations improve payer performance through connected data, intelligent automation, and AI-powered workflows. The platform connects reimbursement market data, contract intelligence, payer policies, and claims data to create a unified view of payer performance. This foundation powers AI-driven workflows that help organizations improve reimbursement, strengthen payer negotiations, and protect revenue.
Media Contact
Ryan Kelly, Senior Director of Marketing at Trek Health
View original content to download multimedia:https://www.prnewswire.com/news-releases/trek-healths-openpayer-surpasses-25-000-monthly-users-in-less-than-4-months-302835858.html
SOURCE Trek Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- X Financial Reports Second Quarter 2026 Unaudited Financial Results
- 74Software: Disclosure of transactions in own shares from August 10 to 14, 2026
- European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share